A feline-focused review of chronic kidney disease-mineral and bone disorders — Part 2: Pathophysiology of calcium disorders and extraosseous calcification
Authors:
- 1 September 2021
- journal article
- review article
- Published by Elsevier in The Veterinary Journal
- Vol. 275, 105718
Abstract
No abstract availableKeywords
This publication has 120 references indexed in Scilit:
- A protective role for FGF-23 in local defence against disrupted arterial wall integrity?Molecular and Cellular Endocrinology, 2013
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney diseaseKidney International, 2010
- Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjectsBiochemical and Biophysical Research Communications, 2010
- Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patientsNephrology Dialysis Transplantation, 2010
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney DiseaseCirculation, 2009
- Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patientsBone, 2009
- Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly menEuropean Journal of Endocrinology, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987